The Science Core exists to provide reagents and services to the various projects within this Program Project grant, and to the Neuropathology and Animal Cores. The need for specific reagents and services are often common to multiple projets and cores, as they are for projects on other Program Project grants. The most efficient method of operation for providing reagents and service requiring complex, expensive equipment is therefore via a central core with highly skilled staff. For this renewal of the Program Project, the Science Core will purify prion protein (PrP) from infected rodent brains for structural studies in Project 2 , in addition to use as standards in Projects 1 and 3. It will also provide a variety recombinant Fabs and monoclonal anti- PrP antibodies, in addition to developing new anti-PrP antibodies with higher affinities. These reagents will be required in large quantities for Western blotting in projects 1, 2 and 3, immunohistochemistry by the Neuropthology core (Core C), and as specific binding controls in Project 4. Recombinant PrP will required for the screening assays in Project 3, in addition to its use as standrds in all other Projects. In addition, the Science Core will provide screening of transgenic mice from the Animal Core (Core D), particularly in support of Project for the production of novel mouse models to test the drugs developed in Projects 2 and 3. Lastly, quinacrine biodistribution studies for both human tissues from Project! and mouse tissue from Core D (in support of project 2), will be performed by the Science Core.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG002132-33
Application #
8429419
Study Section
Special Emphasis Panel (ZAG1-ZIJ-2)
Project Start
Project End
2015-01-31
Budget Start
2013-02-01
Budget End
2014-01-31
Support Year
33
Fiscal Year
2013
Total Cost
$210,539
Indirect Cost
$69,268
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
O'Brien, Connor J; Droege, Daniel G; Jiu, Alexander Y et al. (2018) Photoredox Cyanomethylation of Indoles: Catalyst Modification and Mechanism. J Org Chem 83:8926-8935
Condello, Carlo; Lemmin, Thomas; Stöhr, Jan et al. (2018) Structural heterogeneity and intersubject variability of A? in familial and sporadic Alzheimer's disease. Proc Natl Acad Sci U S A 115:E782-E791
Woerman, Amanda L; Kazmi, Sabeen A; Patel, Smita et al. (2018) MSA prions exhibit remarkable stability and resistance to inactivation. Acta Neuropathol 135:49-63
Yang, Bing; Wu, Haifan; Schnier, Paul D et al. (2018) Proximity-enhanced SuFEx chemical cross-linker for specific and multitargeting cross-linking mass spectrometry. Proc Natl Acad Sci U S A 115:11162-11167
Irimata, Katherine E; Dugger, Brittany N; Wilson, Jeffrey R (2018) Impact of the Presence of Select Cardiovascular Risk Factors on Cognitive Changes among Dementia Subtypes. Curr Alzheimer Res 15:1032-1044
Nick, Mimi; Wu, Yibing; Schmidt, Nathan W et al. (2018) A long-lived A? oligomer resistant to fibrillization. Biopolymers 109:e23096
Woerman, Amanda L; Watts, Joel C; Aoyagi, Atsushi et al. (2018) ?-Synuclein: Multiple System Atrophy Prions. Cold Spring Harb Perspect Med 8:
Woerman, Amanda L; Kazmi, Sabeen A; Patel, Smita et al. (2018) Familial Parkinson's point mutation abolishes multiple system atrophy prion replication. Proc Natl Acad Sci U S A 115:409-414
Johnson, Noah R; Condello, Carlo; Guan, Shenheng et al. (2017) Evidence for sortilin modulating regional accumulation of human tau prions in transgenic mice. Proc Natl Acad Sci U S A 114:E11029-E11036
Gerkin, Richard C; Adler, Charles H; Hentz, Joseph G et al. (2017) Improved diagnosis of Parkinson's disease from a detailed olfactory phenotype. Ann Clin Transl Neurol 4:714-721

Showing the most recent 10 out of 363 publications